COSSU, MARIA VITTORIA
 Distribuzione geografica
Continente #
NA - Nord America 632
EU - Europa 308
AS - Asia 212
AF - Africa 31
SA - Sud America 22
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1217
Nazione #
US - Stati Uniti d'America 604
CN - Cina 132
IT - Italia 116
GB - Regno Unito 63
ES - Italia 27
FR - Francia 22
CA - Canada 18
DE - Germania 18
NL - Olanda 15
ZA - Sudafrica 15
KR - Corea 13
IN - India 12
JP - Giappone 12
BR - Brasile 11
TR - Turchia 11
CH - Svizzera 10
MX - Messico 9
TW - Taiwan 8
SE - Svezia 7
RU - Federazione Russa 6
UA - Ucraina 6
BE - Belgio 5
AR - Argentina 4
AU - Australia 4
CO - Colombia 4
ET - Etiopia 4
ID - Indonesia 4
MY - Malesia 4
NZ - Nuova Zelanda 4
VN - Vietnam 4
CZ - Repubblica Ceca 3
HK - Hong Kong 3
IE - Irlanda 3
KE - Kenya 3
NG - Nigeria 3
PH - Filippine 3
CL - Cile 2
IR - Iran 2
LT - Lituania 2
MW - Malawi 2
PG - Papua Nuova Guinea 2
SG - Singapore 2
A1 - ???statistics.table.value.countryCode.A1??? 1
BO - Bolivia 1
BW - Botswana 1
CD - Congo 1
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
IL - Israele 1
JM - Giamaica 1
NO - Norvegia 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
UG - Uganda 1
Totale 1217
Città #
Fairfield 81
Houston 63
Seattle 59
Beijing 48
Woodbridge 47
Ashburn 37
Buffalo 37
Cambridge 32
Milan 32
Ann Arbor 30
Santa Cruz 24
Wilmington 20
Changsha 12
Florence 12
Shanghai 11
Ottawa 9
Hebei 8
Wuhan 8
Lund 7
Madrid 7
San Diego 7
Southend 7
Clearwater 6
Shenyang 6
Taipei 6
Toronto 6
Guangzhou 5
Las Vegas 5
Los Angeles 5
Muizenberg 5
Riva 5
Wageningen 5
Chicago 4
Duncan 4
Guiyang 4
Molina de Segura 4
Mountain View 4
Phoenix 4
Rome 4
Talamanca de Jarama 4
Tijuana 4
Zurich 4
Augusta 3
Chengdu 3
Dallas 3
Izmir 3
London 3
Malatya 3
Mexico 3
Nihon'odori 3
Pittsburgh 3
Rubizhne 3
Stanford 3
University Park 3
Yellow Springs 3
Zhangzhou 3
Ashhurst 2
Atlanta 2
Bellevue 2
Borlo 2
Brasília 2
Buenos Aires 2
Dong Ket 2
Easton 2
Geneva 2
Glasgow 2
Glenwood 2
Hanoi 2
Hyderabad 2
Lake Forest 2
Medellín 2
Milpitas 2
Modena 2
Munro 2
Nanjing 2
New York 2
Norwalk 2
Parsippany 2
Rotterdam 2
Saint Albans 2
Salamanca 2
Seoul 2
Swindon 2
Sydney 2
Tokyo 2
Utrecht 2
Véry 2
Wiesbaden 2
Accrington 1
Alghero 1
Athens 1
Auckland 1
Bangalore 1
Barcelona 1
Basel 1
Basking Ridge 1
Bellingham 1
Belo Horizonte 1
Bergen 1
Bilbao 1
Totale 810
Nome #
Long term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicenter cohort of HIV1-infected, virologically suppressed patients, file dfa8b99f-a71d-748b-e053-3a05fe0a3a96 583
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies : evidence from Phase I studies in healthy volunteers, file dfa8b993-64f0-748b-e053-3a05fe0a3a96 144
A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48weeks' observational data, file dfa8b999-d327-748b-e053-3a05fe0a3a96 137
Maraviroc reduces arterial stiffness in PI-treated HIV-infected patients, file dfa8b995-e2fa-748b-e053-3a05fe0a3a96 109
Cohort profile : The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE), file dfa8b9a0-3259-748b-e053-3a05fe0a3a96 90
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression, file dfa8b9a5-22a7-748b-e053-3a05fe0a3a96 77
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post_treatment hospitalisation status, file dfa8b9a1-ea04-748b-e053-3a05fe0a3a96 58
Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study, file dfa8b9a0-81b3-748b-e053-3a05fe0a3a96 42
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients, file dfa8b9a0-ac18-748b-e053-3a05fe0a3a96 6
Dolutegravir plus rilpivirine as a switch option in cART-experienced patients : 96-week data, file dfa8b99a-8d91-748b-e053-3a05fe0a3a96 5
An evaluation of elvitegravir plus cobicistat plus tenofovir alafenamide plus emtricitabine as a single-tablet regimen for the treatment of HIV in children and adolescents, file dfa8b99d-10b5-748b-e053-3a05fe0a3a96 4
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial, file dfa8b9a5-c143-748b-e053-3a05fe0a3a96 4
Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study, file dfa8b9a5-8252-748b-e053-3a05fe0a3a96 3
Brief Report : Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic, file dfa8b9a9-75b9-748b-e053-3a05fe0a3a96 3
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation, file dfa8b9a1-6dd4-748b-e053-3a05fe0a3a96 2
Salvage therapy or simplification of salvage regimens with dolutegravir plus ritonavir-boosted darunavir dual therapy in highly cART-experienced subjects : an Italian cohort, file dfa8b997-5588-748b-e053-3a05fe0a3a96 1
A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients, file dfa8b99c-571b-748b-e053-3a05fe0a3a96 1
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy, file dfa8b9a3-7ec0-748b-e053-3a05fe0a3a96 1
Totale 1270
Categoria #
all - tutte 1396
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1396


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201822 0001 11 03 1447
2018/2019115 31663 53 59 11132516
2019/2020352 15111026 2571 3738 30263231
2020/2021368 30251737 2040 4720 28353237
2021/2022377 29372238 4421 4122 19255524
2022/202322 19300 00 00 0000
Totale 1270